Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1986
[In vitro predictive activity assay of agents based on dynamic cellular morphological findings--clinical application]
M Oguro, T Takagi
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 1, 1991
[Combination cancer chemotherapy using a DNA topoisomerase inhibitor CPT-11, as a core agent--the in vitro evaluation]
M Oguro, Y Seki
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
(2"-R)-4'-o-tetrahydropyranyladriamycin, a new anthracycline derivative; its effectiveness in lymphoid malignancies
T Takagi, M Oguro
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 1, 1982
[Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine]
M Oguro, T Takagi
Journal of Biochemistry
|
June 1, 1982
The inhibitory mode of aphidicolin on DNA synthesis in NaCl-treated HeLa cell nuclei
M Oguro, H Nagano
Journal of Biochemistry
|
January 1, 1983
Reconstitution of endogenous DNA synthesis in isolated nuclei and template activity of chromatin with respect to mode of inhibition by aphidicolin
M Oguro, H Nagano
Journal of Biochemistry
|
August 1, 1982
Inhibition of eukaryotic DNA polymerase-alpha by polydeoxynucleotides
M Oguro, H Nagano
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 1, 1984
[Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy]
T Takagi, M Oguro, K Iwabuchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 1, 1992
[BH-AC.nitrosourea-therapy for refractory or relapsed malignant lymphoma]
C Sakai, T Takagi, M Oguro
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
A lymphoma cell line resistant to 4-piperidinopiperidine was less sensitive to CPT-11
Y Onishi, M Oguro, H Kizaki
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1986
[In vitro predictive activity assay of agents based on dynamic cellular morphological findings--clinical application]
M Oguro, T Takagi
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 1, 1991
[Combination cancer chemotherapy using a DNA topoisomerase inhibitor CPT-11, as a core agent--the in vitro evaluation]
M Oguro, Y Seki
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
(2"-R)-4'-o-tetrahydropyranyladriamycin, a new anthracycline derivative; its effectiveness in lymphoid malignancies
T Takagi, M Oguro
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 1, 1982
[Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine]
M Oguro, T Takagi
Journal of Biochemistry
|
June 1, 1982
The inhibitory mode of aphidicolin on DNA synthesis in NaCl-treated HeLa cell nuclei
M Oguro, H Nagano
Journal of Biochemistry
|
January 1, 1983
Reconstitution of endogenous DNA synthesis in isolated nuclei and template activity of chromatin with respect to mode of inhibition by aphidicolin
M Oguro, H Nagano
Journal of Biochemistry
|
August 1, 1982
Inhibition of eukaryotic DNA polymerase-alpha by polydeoxynucleotides
M Oguro, H Nagano
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 1, 1984
[Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy]
T Takagi, M Oguro, K Iwabuchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 1, 1992
[BH-AC.nitrosourea-therapy for refractory or relapsed malignant lymphoma]
C Sakai, T Takagi, M Oguro
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
A lymphoma cell line resistant to 4-piperidinopiperidine was less sensitive to CPT-11
Y Onishi, M Oguro, H Kizaki
Page
of 8